Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Broad Institute, Inc. — Verve Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Broad Institute, Inc.

Broad Institute, Inc.

10% owner at Verve Therapeutics, Inc. · on record since Jun 23, 2021

Insider trading activity of Broad Institute, Inc.

Transactions on record: 1; since Jun 23, 2021

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jun 23, 2021

Figures computed from official regulatory filings — methodology.

Companies where Broad Institute, Inc. has traded

Verve Therapeutics, Inc.1 tx · Jun 23, 2021

Track record of Broad Institute, Inc.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Broad Institute, Inc.

Co-insiders of Broad Institute, Inc.

ADELMAN BURT AVerve Therapeutics, Inc.
Alphabet Inc.Verve Therapeutics, Inc.
ARCH Venture Fund X, L.P.Verve Therapeutics, Inc.
ARCH Venture Fund X Overage, L.P.Verve Therapeutics, Inc.
ARCH Venture Partners X, LLCVerve Therapeutics, Inc.
ARCH Venture Partners X, L.P.Verve Therapeutics, Inc.
ARCH Venture Partners X Overage, L.P.Verve Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Ashe Andrew D.Verve Therapeutics, Inc.

Beam Therapeutics Inc.Verve Therapeutics, Inc.

Beaudoin MargaretVerve Therapeutics, Inc.

Bellinger AndrewVerve Therapeutics, Inc.

Biomatics Capital Partners, L.P.Verve Therapeutics, Inc.

Burow KristinaVerve Therapeutics, Inc.

Casdin Partners Master Fund, L.P.Verve Therapeutics, Inc.

Casdin Private Growth Equity Fund, L.P.Verve Therapeutics, Inc.

Chen BihuaVerve Therapeutics, Inc.

COATS LONNELVerve Therapeutics, Inc.

Cormorant Asset Management, LPVerve Therapeutics, Inc.

Cormorant Global Healthcare Master Fund, LPVerve Therapeutics, Inc.

Cormorant Private Healthcare Fund III LPVerve Therapeutics, Inc.

CRANDELL KEITHVerve Therapeutics, Inc.

Cumbo AlexanderVerve Therapeutics, Inc.

Dorval AllisonVerve Therapeutics, Inc.

Evans John M.Verve Therapeutics, Inc.

Fiedorek Fred T.Verve Therapeutics, Inc.

FMR LLCVerve Therapeutics, Inc.

GILLIS STEVENVerve Therapeutics, Inc.

Green JeremyVerve Therapeutics, Inc.

GV 2017 GP, L.L.C.Verve Therapeutics, Inc.

GV 2017 GP, L.P.Verve Therapeutics, Inc.

GV 2017, L.P.Verve Therapeutics, Inc.

GV 2019 GP, L.L.C.Verve Therapeutics, Inc.

GV 2019 GP, L.P.Verve Therapeutics, Inc.

GV 2019, L.P.Verve Therapeutics, Inc.

GV 2023 GP, L.L.C.Verve Therapeutics, Inc.

GV 2023 GP, L.P.Verve Therapeutics, Inc.

GV 2023, L.P.Verve Therapeutics, Inc.

Joung Jae KeithVerve Therapeutics, Inc.

Kathiresan SekarVerve Therapeutics, Inc.

Lister TroyVerve Therapeutics, Inc.

Logos Global Management LPVerve Therapeutics, Inc.

MacLean Michael FVerve Therapeutics, Inc.

Mikhail SheilaVerve Therapeutics, Inc.

Morrison Jodie PopeVerve Therapeutics, Inc.

NELSEN ROBERTVerve Therapeutics, Inc.

Nickerson JoanVerve Therapeutics, Inc.

Novo A/SVerve Therapeutics, Inc.

Politi JasonVerve Therapeutics, Inc.

Redmile Group, LLCVerve Therapeutics, Inc.

Rock Springs Capital LLCVerve Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Verve Therapeutics, Inc.	Jun 23, 2021	Other	387,830	0.00 USD	$0	SEC